These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36932988)

  • 1. Promise of bile circulating tumor DNA in biliary tract cancers.
    Kearney JF; Weighill D; Yeh JJ
    Cancer; 2023 Jun; 129(11):1643-1645. PubMed ID: 36932988
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Advanced Biliary Tract Cancer.
    Chen C; Wang T; Yang M; Song J; Huang M; Bai Y; Su H
    Pathol Oncol Res; 2021; 27():1609879. PubMed ID: 34720757
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers.
    Okamura R; Kurzrock R; Mallory RJ; Fanta PT; Burgoyne AM; Clary BM; Kato S; Sicklick JK
    Int J Cancer; 2021 Feb; 148(3):702-712. PubMed ID: 32700810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterisation of six human biliary tract cancer cell lines.
    Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
    Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives.
    Rizzo A; Ricci AD; Tavolari S; Brandi G
    Cancer Genomics Proteomics; 2020; 17(5):441-452. PubMed ID: 32859625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of biliary tract cancers.
    Fava G; Marzioni M; Benedetti A; Glaser S; DeMorrow S; Francis H; Alpini G
    Cancer Lett; 2007 Jun; 250(2):155-67. PubMed ID: 17069969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.
    Andreotti G; Chen J; Gao YT; Rashid A; Chen BE; Rosenberg P; Sakoda LC; Deng J; Shen MC; Wang BS; Han TQ; Zhang BH; Yeager M; Welch R; Chanock S; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):525-34. PubMed ID: 18296645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
    Hou L; Xu J; Gao YT; Rashid A; Zheng SL; Sakoda LC; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Meyers DA; Fraumeni JF; Hsing AW
    Int J Cancer; 2006 Jun; 118(11):2847-53. PubMed ID: 16381022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China.
    Zhang M; Huang WY; Andreotti G; Gao YT; Rashid A; Chen J; Sakoda LC; Shen MC; Wang BS; Chanock S; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2123-7. PubMed ID: 18708406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
    Itoi T; Shinohara Y; Takeda K; Nakamura K; Shimizu M; Ohyashiki K; Hisatomi H; Nakano H; Moriyasu F
    Int J Mol Med; 2001 Mar; 7(3):281-7. PubMed ID: 11179508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
    Kitamura T; Srivastava J; DiGiovanni J; Kiguchi K
    Mol Carcinog; 2015 Jun; 54(6):459-72. PubMed ID: 24839254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China.
    Ueki T; Hsing AW; Gao YT; Wang BS; Shen MC; Cheng J; Deng J; Fraumeni JF; Rashid A
    Clin Cancer Res; 2004 Mar; 10(5):1717-25. PubMed ID: 15014024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
    Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers.
    Li YC; Li KS; Liu ZL; Tang YC; Hu XQ; Li XY; Shi AD; Zhao LM; Shu LZ; Lian S; Yan ZD; Huang SH; Sheng GL; Song Y; Liu YJ; Huan F; Zhang MH; Zhang ZL
    Front Immunol; 2022; 13():1049812. PubMed ID: 36389727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
    Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
    Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China.
    Park SK; Andreotti G; Sakoda LC; Gao YT; Rashid A; Chen J; Chen BE; Rosenberg PS; Shen MC; Wang BS; Han TQ; Zhang BH; Yeager M; Chanock S; Hsing AW
    Carcinogenesis; 2009 Apr; 30(4):606-14. PubMed ID: 19168589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology.
    Shi C; Chandrasekaran A; Thuluvath PJ; Karikari C; Argani P; Goggins M; Maitra A; Eshleman JR
    J Mol Diagn; 2009 Nov; 11(6):583-9. PubMed ID: 19815696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
    Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.